Drug Information

Drug General Information
Drug ID
D0W3UH
Former ID
DIB002831
Drug Name
QLT-091568
Synonyms
OT-730; Beta adrenoceptor antagonist prodrug (glaucoma/ocular hypertension), Othera
Indication Glaucoma [ICD9: 365; ICD10:H40-H42] Phase 1/2 [522437]
Company
Othera Pharmaceuticals Inc
Target and Pathway
Target(s) Beta-3 adrenergic receptor Target Info Antagonist [551556]
KEGG Pathway Calcium signaling pathway
cGMP-PKG signaling pathway
Neuroactive ligand-receptor interaction
Endocytosis
Salivary secretion
PANTHER Pathway Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
Beta3 adrenergic receptor signaling pathway
Reactome Adrenoceptors
G alpha (s) signalling events
WikiPathways Monoamine GPCRs
Calcium Regulation in the Cardiac Cell
GPCRs, Class A Rhodopsin-like
GPCR ligand binding
GPCR downstream signaling
References
Ref 522437ClinicalTrials.gov (NCT00753168) Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma. U.S. National Institutes ofHealth.
Ref 551556Clinical pipeline report, company report or official report of QLT Inc.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.